Literature DB >> 19219540

Experiences and decisions that motivate women at increased risk of breast cancer to participate in an experimental screening program.

Michelle Proulx1, Marie-Dominique Beaulieu, Christine Loignon, Marie-Hélène Mayrand, Christine Maugard, Nathalie Bellavance, Diane Provencher.   

Abstract

Although the discovery of mutations on BRCA1 and BRCA2 genes associated with high breast cancer risk has given rise to screening and surveillance initiatives, there is little documentation on why high-risk women choose to enter screening programs. The objective of this qualitative study was to develop a detailed understanding of the experiences and decisions that motivate women with increased risk of hereditary breast cancer to participate in the multicentered Quebec experimental breast screening program. Our study involved 21 participants who were either BRCA carriers or at risk and untested. These women were interviewed while participating in the screening program. Our study demonstrates that intensive screening programs may provide valuable reassurance for women with increased familial risk of hereditary breast cancer, who count on early detection and rapid response from professionals if and when a problem arises. Health professionals must take these and others concerns into account to ensure their interventions are most consistent with women's needs.

Entities:  

Mesh:

Year:  2009        PMID: 19219540     DOI: 10.1007/s10897-008-9202-z

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  31 in total

1.  A qualitative study of the information needs of high-risk women undergoing prophylactic oophorectomy.

Authors:  N Hallowell
Journal:  Psychooncology       Date:  2000 Nov-Dec       Impact factor: 3.894

2.  Psychosocial factors predicting BRCA1/BRCA2 testing decisions in members of hereditary breast and ovarian cancer families.

Authors:  B B Biesecker; N Ishibe; D W Hadley; T R Giambarresi; R G Kase; C Lerman; J P Struewing
Journal:  Am J Med Genet       Date:  2000-08-14

3.  Attitudes and distress levels in women at risk to carry a BRCA1/BRCA2 gene mutation who decline genetic testing.

Authors:  Litanja Lodder; Petra G Frets; R Willem Trijsburg; Jan G M Klijn; Caroline Seynaeve; Madeleine M A Tilanus; Carina C M Bartels; E Johanna Meijers-Heijboer; Leon C Verhoog; Martinus F Niermeijer
Journal:  Am J Med Genet A       Date:  2003-06-15       Impact factor: 2.802

4.  Legal perspectives on mammography and self-referral.

Authors:  J S Spratt; S W Spratt
Journal:  Cancer       Date:  1992-01-15       Impact factor: 6.860

5.  Counseling families with hereditary breast and ovarian cancer: A psychosocial perspective.

Authors:  M P Richards; N Hallowell; J M Green; F Murton; H Statham
Journal:  J Genet Couns       Date:  1995-09       Impact factor: 2.537

6.  Breast and ovarian cancer screening practices in healthy women with a strong family history of breast or ovarian cancer.

Authors:  Claudine Isaacs; Beth N Peshkin; Marc Schwartz; Tiffani A Demarco; David Main; Caryn Lerman
Journal:  Breast Cancer Res Treat       Date:  2002-01       Impact factor: 4.872

7.  Participation in breast cancer susceptibility testing protocols: influence of recruitment source, altruism, and family involvement on women's decisions.

Authors:  G Geller; T Doksum; B A Bernhardt; S A Metz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1999-04       Impact factor: 4.254

8.  What information do breast cancer screening programmes provide to Italian women?

Authors:  Livia Giordano; Maria Rowinski; Giuseppe Gaudenzi; Nereo Segnan
Journal:  Eur J Public Health       Date:  2005-02       Impact factor: 3.367

9.  Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing.

Authors:  C Lerman; C Hughes; R T Croyle; D Main; C Durham; C Snyder; A Bonney; J F Lynch; S A Narod; H T Lynch
Journal:  Prev Med       Date:  2000-07       Impact factor: 4.018

10.  Psychological impact of screening for familial ovarian cancer.

Authors:  F J Wardle; W Collins; A L Pernet; M I Whitehead; T H Bourne; S Campbell
Journal:  J Natl Cancer Inst       Date:  1993-04-21       Impact factor: 13.506

View more
  3 in total

1.  Sources of uncertainty about daughters' breast cancer risk that emerge during genetic counseling consultations.

Authors:  Carma L Bylund; Carla L Fisher; Dale Brashers; Shawna Edgerson; Emily A Glogowski; Sherry R Boyar; Yelena Kemel; Sara Spencer; David Kissane
Journal:  J Genet Couns       Date:  2011-08-11       Impact factor: 2.537

2.  "It was an Emotional Baby": Previvors' Family Planning Decision-Making Styles about Hereditary Breast and Ovarian Cancer Risk.

Authors:  Marleah Dean; Emily A Rauscher
Journal:  J Genet Couns       Date:  2017-01-30       Impact factor: 2.537

3.  Women's constructions of the 'right time' to consider decisions about risk-reducing mastectomy and risk-reducing oophorectomy.

Authors:  A Fuchsia Howard; Joan L Bottorff; Lynda G Balneaves; Charmaine Kim-Sing
Journal:  BMC Womens Health       Date:  2010-08-05       Impact factor: 2.809

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.